|
Oct 9
|
Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
|
|
Oct 1
|
INOVIO to Present at Upcoming Scientific Conferences
|
|
Jul 25
|
Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107
|
|
Jul 25
|
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
|
|
May 14
|
Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 14
|
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
|
|
May 13
|
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
|
May 5
|
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
|
|
May 1
|
INOVIO Reports Inducement Grants Under Inducement Plan
|
|
Apr 29
|
INOVIO to Participate in Upcoming Investor Conferences in May
|
|
Apr 29
|
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
|
|
Apr 15
|
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
|
|
Mar 26
|
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
|
|
Mar 8
|
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
|
|
Mar 7
|
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
|
|
Mar 7
|
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
|
|
Mar 6
|
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|
|
Feb 2
|
INOVIO Reports Inducement Grant Under Inducement Plan
|